Sign In
Buy ELTP
$0.381
-0.0189 (-4.73%)
At Close: Jun 05, 2026
2 Outperform Rated Small Caps with Recent Pull-backs
05:56pm, Monday, 11'th Aug 2025
ELTP and TSSI are growth stories with recent material pull-backs.
Financials for First Quarter of Fiscal Year 2026 Ended June 30, 2025 will be released on Thursday, August 14, 2025 Northvale, New Jersey--(Newsfile Corp. - August 8, 2025) - Elite Pharmaceuticals, Inc
Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump
01:06pm, Thursday, 03'rd Jul 2025
ELTP posts record fiscal 2025 revenues and operating income gains, fueled by new launches and expanding generics market share.
Elite Pharmaceuticals, Inc. (ELTP) Q4 2025 Earnings Call Transcript
05:22pm, Tuesday, 01'st Jul 2025
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2025 Earnings Conference Call July 1, 2025 11:30 AM ET Company Participants Carter J. Ward - CFO, Secretary & Treasurer Nasrat Hakim - Chairman, CEO & Presi
Conference Call Scheduled for Tuesday, July 1 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - June 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specia
Financials for Fiscal Year 2025 Ended March 31, 2025 will be released on Monday, June 30, 2025 Northvale, Northvale, New Jersey--(Newsfile Corp. - June 23, 2025) - Elite Pharmaceuticals, Inc. (OTCQB:
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
07:00am, Monday, 16'th Jun 2025
Northvale, New Jersey--(Newsfile Corp. - June 16, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufac
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
07:00am, Monday, 16'th Jun 2025
Northvale, New Jersey--(Newsfile Corp. - June 16, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufac
Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
04:30pm, Wednesday, 30'th Apr 2025
Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
07:00am, Monday, 03'rd Mar 2025
Northvale, New Jersey--(Newsfile Corp. - March 3, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, an
ELTP Stock Falls Following Q3 Earnings Decline, Revenue Down Y/Y
11:05am, Wednesday, 19'th Feb 2025
Elite Pharmaceuticals' third-quarter fiscal 2025 reports a revenue drop and a net loss. However, delayed shipments impact results.
Conference Call Scheduled for Friday, February 14 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - February 13, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a
Financials for the Third Quarter of Fiscal Year 2025 Ended December 31, 2024 will be released on Thursday, February 13, 2025 Northvale, New Jersey--(Newsfile Corp. - February 10, 2025) - Elite Pharmac
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
07:00am, Thursday, 26'th Dec 2024
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
06:00am, Monday, 02'nd Dec 2024
Northvale, New Jersey--(Newsfile Corp. - December 2, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
